Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > Institutions buying hard, read.
View:
Post by HightideHippie on Apr 04, 2021 3:45pm

Institutions buying hard, read.

Marketbeat, in Q1 alone, hedge funds and mutual funds poured a net amount of $190 million into Aphria, and this numberis most likely an underestimate. Yahoo finance has Aphria’s institutional ownership at 19%, up from about 10% a month ago. Rapid increases in institutional ownership are almost always a bullish sign. This change in institutional ownership is unprecedented, and too significant to ignore. While Aphria has already seen a major influx of institutional capital, at 19% there is still a lot of room for institutions to come in and scoop up shares. As this happens, shares will become scarce, and demand will be greater than the supply, and the share price will adjust itself accordingly. With a price to sales ratio of 9.87 and price to book ratio of 3.6, Aphria on a valuation basis is attractive when compared to its peers.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities